Ventoux Biosciences is working to transform treatment for Dupuytren’s and related, under-served, immuno-fibrotic diseases. Founded by a Dupuytren’s patient and propelled by a team with Dupuytren's and fibrosis expertise from bench to bedside – we seek to revolutionize current treatment options via development of novel, first-line, disease-modifying, non-surgical options for patients. Dupuytren's is a chronic, progressive, debilitating and often painful fibrosis of the hands and is >3x more prevalent than Rheumatoid Arthritis. However; no cure and no approved disease slowing agents exist. Unlike RA, surgery remains as the standard of care for Dupuytren's patients.
Following positive anti-fibrotic data in an established scleroderma / dermal fibrosis model, we are working to advance our lead candidate VEN-201 to human studies. Our business strategy is to expedite treatment for patients by leveraging expedited FDA clinical & regulatory pathways.
Dupuytren's impacts ~265m patients across 7 major markets and upwards of 10 million patients in the U.S. alone. VEN-201 represents a potential novel, differentiated, first-line treatment to slow disease progression and help patients maintain hand function and delay potential progression to surgery or surgical interventions.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 315 S Coast Highway 101, Encinitas,california,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.ventouxbio.com/
- Keywords
- Fibrosis, Inflammation, Auto-Immune, Dupuytren's Disease, Ledderhose Disease, Patient Focused.
- HQ
- Encinitas, California
Ventoux Biosciences Questions
Ventoux Biosciences's website is https://www.ventouxbio.com/
Ventoux Biosciences's LinkedIn profile is https://www.linkedin.com/company/ventoux-biosciences
Ventoux Biosciences has
4 employees.
View email and phone details for 4
employees at Ventoux Biosciences.
Ventoux Biosciences's industry is
Biotechnology Research
Ventoux Biosciences's top competitors are
Contineum Therapeutics,
Remote Cfo,
Btb Therapeutics, Inc.,
Berea Bioventures, Llc,
Ugather Cowork,
Argenx,
Vault Bioventures,
Kaer Biotherapeutics Corporation,
Gossamer Bio,
City Therapeutics.
Ventoux Biosciences's categories are Biotechnology Research
Ventoux Biosciences's founding year is 2022
